Magnesium oxide and Performance status decreased - a phase IV clinical study of FDA data

Summary:

Performance status decreased is reported as a side effect among people who take Magnesium oxide (magnesium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Triazolam, and have Insomnia.

The phase IV clinical study analyzes which people have Performance status decreased when taking Magnesium oxide. It is created by eHealthMe based on reports of 18,625 people who have side effects when taking Magnesium oxide from the FDA, and is updated regularly.

What is Magnesium oxide?

Magnesium oxide has active ingredients of magnesium. It is often used in migraine. eHealthMe is studying from 19,022 Magnesium oxide users. Check the latest studies of Magnesium oxide.

What is Performance status decreased?

Performance status decreased is found to be associated with 515 drugs and 636 conditions by eHealthMe. Check the latest studies of Performance status decreased.



On Jul, 10, 2026

18,625 people reported to have side effects when taking Magnesium oxide.
Among them, 13 people (0.07%) have Performance status decreased.

Could Magnesium oxide cause Performance status decreased?

Among these 13 people:

How long have people been on Magnesium oxide when they have Performance status decreased? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Performance status decreased when taking Magnesium oxide? *

  • female: 36.36 %
  • male: 63.64 %

What is the age of people who have Performance status decreased when taking Magnesium oxide? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Magnesium oxide? *

  1. Zyprexa: 2 people, 15.38%
  2. Furosemide: 2 people, 15.38%
  3. Dapagliflozin: 2 people, 15.38%
  4. Levothyroxine Sodium: 2 people, 15.38%
  5. Dilaudid: 2 people, 15.38%
  6. Norvasc: 2 people, 15.38%
  7. Nexium: 2 people, 15.38%
  8. Spironolactone: 2 people, 15.38%
  9. Metformin Hydrochloride: 2 people, 15.38%
  10. Triazolam: 2 people, 15.38%

What are other side effects people have besides Performance status decreased? *

  1. Malaise (a feeling of general discomfort or uneasiness): 3 people, 23.08%
  2. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 23.08%
  3. Malignant Neoplasm Progression (cancer tumour came back): 2 people, 15.38%
  4. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 15.38%
  5. Chronic Kidney Disease: 2 people, 15.38%
  6. Oedema Peripheral (superficial swelling): 2 people, 15.38%
  7. Pain: 2 people, 15.38%
  8. Dehydration (dryness resulting from the removal of water): 2 people, 15.38%
  9. Itching: 2 people, 15.38%
  10. Disease Progression: 2 people, 15.38%

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 4 people, 30.77%
  2. Nausea (feeling of having an urge to vomit): 2 people, 15.38%
  3. Pain: 2 people, 15.38%
  4. Enlarged Prostate: 2 people, 15.38%
  5. Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 1 person, 7.69%
  6. High Blood Pressure: 1 person, 7.69%
  7. Hepatitis B: 1 person, 7.69%
  8. Gastritis - Chronic (long lasting inflammation of stomach): 1 person, 7.69%
  9. Gastric Cancer Stage Iii (the tumour has invaded nearby organs, such as the liver, colon, or spleen. cancer cells have not spread to lymph nodes or to distant organs): 1 person, 7.69%
  10. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium oxide and have Performance status decreased?

- Check whether Performance status decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Magnesium oxide:

Performance status decreased treatments and more:

How severe was Performance status decreased and when was it recovered:

Expand to all the drugs that have ingredients of magnesium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Magnesium oxide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Performance status decreased:

Browse all the conditions that are associated with Performance status decreased:


How the study uses the data?

The study uses data from the FDA. It is based on magnesium (the active ingredients of Magnesium oxide) and Magnesium oxide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: